Teva names new board member

Mr Elstein has been a member of Teva’s senior management since 2005. Mr Elstein most recently held the position of executive vice president of global pharmaceutical resources.

Prior to joining Teva as an executive officer, Mr Elstein served on the company’s board of directors from 1995 to 2004. Mr Elstein has resigned his executive position with the company in order to rejoin its board of directors.

Mr Elstein holds a BSc in physics and mathematics from the Hebrew University in Jerusalem, a MSc in solid state physics from the department of applied physics of the Hebrew University and a diploma of senior business management from the Hebrew University.

Shlomo Yanai, president and CEO of Teva, said: “I would like to thank Amir for his invaluable contribution to Teva over the past four years as a member of our senior management. Throughout his tenure at Teva, Amir made significant contributions to expanding our business and strengthening Teva’s market leadership. I am confident that Teva will continue to benefit from his experience and dedication as a director.”